These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19668174)

  • 1. Beyond the biotech IPO: a brave new world.
    Booth BL
    Nat Biotechnol; 2009 Aug; 27(8):705-9. PubMed ID: 19668174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public biotech 2008--the numbers.
    Huggett B; Hodgson J; Lähteenmäki R
    Nat Biotechnol; 2009 Aug; 27(8):710-21. PubMed ID: 19668175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotech's new colossus. Move over, Big Pharma. Amgen boasts better growth.
    Stipp D
    Fortune; 2002 Apr; 145(8):144-6, 148, 150. PubMed ID: 11961884
    [No Abstract]   [Full Text] [Related]  

  • 4. [Change the world through business partnering - commercialization of biotechnology and open-innovation].
    Tsukamoto Y
    Nihon Yakurigaku Zasshi; 2013 May; 141(5):268-74. PubMed ID: 23665558
    [No Abstract]   [Full Text] [Related]  

  • 5. Big pharma swallows biotech's pride.
    Huggett B
    Nat Biotechnol; 2008 Sep; 26(9):955-6. PubMed ID: 18779785
    [No Abstract]   [Full Text] [Related]  

  • 6. Becoming an American company: a holistic approach to decision making.
    Banerjee PK
    Nat Biotechnol; 2007 Mar; 25(3):277-80. PubMed ID: 17447269
    [No Abstract]   [Full Text] [Related]  

  • 7. Crystal gazing: biotech's financial outlook: the biotech analyst's view.
    Schmidt E
    Nat Biotechnol; 2006 Mar; 24(3):261-2. PubMed ID: 16525376
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotech rallies in Q3.
    Yang W
    Nat Biotechnol; 2010 Nov; 28(11):1144. PubMed ID: 21057476
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotech plummets in 3Q11.
    Yang W
    Nat Biotechnol; 2011 Nov; 29(11):962. PubMed ID: 22068525
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotech's baby boom.
    Hodgson J
    Nat Biotechnol; 2019 May; 37(5):502-512. PubMed ID: 31053818
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotech jostles with pharma for slice of HIV market.
    Katsnelson A
    Nat Biotechnol; 2006 Jan; 24(1):3-4. PubMed ID: 16404375
    [No Abstract]   [Full Text] [Related]  

  • 12. Making it in the biotech business.
    Gewin V
    Nature; 2005 May; 435(7038):124-5. PubMed ID: 15875029
    [No Abstract]   [Full Text] [Related]  

  • 13. Micro moulding: the route to a successful product.
    Whiteside B; Manser P
    Med Device Technol; 2009; 20(2):18, 20-1. PubMed ID: 19405338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scaling the biobusiness information mountain.
    Williams G; Walsh G
    Nat Biotechnol; 2005 Jan; 23(1):147-9. PubMed ID: 15706638
    [No Abstract]   [Full Text] [Related]  

  • 15. The biotech drug market.
    Lawrence S
    Nat Biotechnol; 2004 Dec; 22(12):1496. PubMed ID: 15583645
    [No Abstract]   [Full Text] [Related]  

  • 16. Biotech's wonder ride.
    Rynecki D
    Fortune; 2000 Mar; 141(5):435-6. PubMed ID: 10788046
    [No Abstract]   [Full Text] [Related]  

  • 17. Biotech's billion dollar breakthrough.
    Stipp D
    Fortune; 2003 May; 147(10):96-8, 100, 103. PubMed ID: 12776500
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotech drug market steadily expands.
    Lawrence S
    Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279
    [No Abstract]   [Full Text] [Related]  

  • 19. Biotech on pace for record year.
    Yang W
    Nat Biotechnol; 2011 Sep; 29(9):780. PubMed ID: 21904312
    [No Abstract]   [Full Text] [Related]  

  • 20. Bonsai biotech.
    Bains W
    Nat Biotechnol; 2009 Mar; 27(3):233. PubMed ID: 19270667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.